findmyKOL
Clinical trialNCT00228592TerminatedPhase 2Interventional

HepeX-B in Post Hepatic Allografts for Treatment of End Stage Liver Disease Due to Hepatitis B Infection

SponsorCubist Pharmaceuticals LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)Hepatitis BLiver Transplantation
View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

20 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

France
  • Centre Hepato-Biliaire Hospital Paul Brousse

    Paris, France

Germany
  • Humbolt University Virchow Clinic Dept. Viceral and Transplant Surgery

    Berlin, Germany

Israel
  • Hadassah University Hospital

    Jerusalem, Israel

  • Rabin Medical Center

    Petah Tikva, Israel

  • Tel-Aviv Sourasky Medical Center

    Tel Aviv, Israel

New Zealand
  • Auckland City Hospital

    Auckland, New Zealand

Spain
  • Hospital la Fe Servicio de Medicina Degestiva

    Valencia, Spain

United Kingdom
  • Royal Free Hospital

    London, United Kingdom

United States
  • Ucla

    Los Angeles, California, United States

  • California Pacific Medical Center

    San Francisco, California, United States

  • Ucsf

    San Francisco, California, United States

  • Mayo Clinic

    Rochester, Minnesota, United States

  • University of Nebraska

    Omaha, Nebraska, United States

  • Mt. Sinai

    New York, New York, United States

  • University of North Carolina

    Chapel Hill, North Carolina, United States

  • University of Cincinnati Medical Center

    Cincinnati, Ohio, United States

  • University of Pennsylvania Health System

    Philadelphia, Pennsylvania, United States

  • University of Virginia

    Charlottesville, Virginia, United States

  • Metropolitan Liver Diseases/gastroenterology Center

    Fairfax, Virginia, United States

  • Virginia Commonwealth University Health System

    Richmond, Virginia, United States

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
Primary completion
Completion
31 Aug 2005
Last update posted
13 Feb 2007
Registered enrollment
Registry id
NCT00228592

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.